ArticleAmerican journal of nuclear medicine and molecular imaging2018
Article in American journal of nuclear medicine and molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 27 citations in OpenAlex.
- Mitigating bladder signal inEJNMMI physics · 2026Article
- Ultrasound wrist mapping to develop a noninvasive radiation detector for dynamic positron emission tomography.Scientific reports · 2026Article
- Impact of different parametric Patlak imaging approaches and comparison with a 2-tissue compartment pharmacokinetic model with a long axial field-of-view (LAFOV) PET/CT in oncological patients.European journal of nuclear medicine and molecular imaging · 2025Article
- Real world experience with [EJNMMI reports · 2024Article
- Dual-time-point dynamicAnnals of nuclear medicine · 2024Article
- Direct Patlak Reconstruction of [International journal of molecular sciences · 2023Article
- Diagnostic value of two-time point [Scientific reports · 2023Article
- Is there more than meets the eye in PSMA imaging in prostate cancer with PET/MRI? Looking closer at uptake time, correlation with PSA and Gleason score.European journal of hybrid imaging · 2023Article
- Multiparametric dynamic whole-body PSMA PET/CT using [EJNMMI research · 2023Article
- Inter-pass motion correction for whole-body dynamic PET and parametric imaging.IEEE transactions on radiation and plasma medical sciences · 2023Article
- Hybrid imaging with [Cancer imaging : the official publication of the International Cancer Imaging Society · 2022Article
- Is there a diagnostic benefit of late-phase abdomino-pelvic PET/CT after urination as part of whole-bodyEJNMMI research · 2022Article
- Diagnostic performance of 99mTc-HYNIC-PSMA SPECT/CT for biochemically recurrent prostate cancer after radical prostatectomy.Frontiers in oncology · 2022Article
- Pharmacokinetic studies of [European journal of nuclear medicine and molecular imaging · 2021Article
- Early differences in dynamic uptake of 68Ga-PSMA-11 in primary prostate cancer: A test-retest study.PloS one · 2021Article
- Kinetic modeling and parametric imaging with dynamic PET for oncological applications: general considerations, current clinical applications, and future perspectives.European journal of nuclear medicine and molecular imaging · 2021Review
- Article
- Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative DynamicCancers · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
30510852PMC6261880W2982624046What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.